187 related articles for article (PubMed ID: 10645206)
1. Raltitrexed (Tomudex) in combination treatment for colorectal cancer: new perspectives.
Van Cutsem E
Eur J Cancer; 1999 Mar; 35 Suppl 1():S1-2. PubMed ID: 10645206
[TBL] [Abstract][Full Text] [Related]
2. The use of irinotecan, oxaliplatin and raltitrexed for the treatment of advanced colorectal cancer: systematic review and economic evaluation.
Hind D; Tappenden P; Tumur I; Eggington S; Sutcliffe P; Ryan A
Health Technol Assess; 2008 May; 12(15):iii-ix, xi-162. PubMed ID: 18462574
[TBL] [Abstract][Full Text] [Related]
3. [Combination of 5-Fluorouracil and folinic acid--is it still the standard therapy for advanced colorectal carcinoma?].
Carnaghi C; Zucali P; Garassino I
Tumori; 2000; 86(5 Suppl 2):S19-25. PubMed ID: 11195298
[TBL] [Abstract][Full Text] [Related]
4. Current treatments and future perspectives in colorectal and gastric cancer.
Wilke HJ; Van Cutsem E
Ann Oncol; 2003; 14 Suppl 2():ii49-55. PubMed ID: 12810459
[TBL] [Abstract][Full Text] [Related]
5. Raltitrexed: current clinical status and future directions.
Van Cutsem E; Cunningham D; Maroun J; Cervantes A; Glimelius B
Ann Oncol; 2002 Apr; 13(4):513-22. PubMed ID: 12056700
[TBL] [Abstract][Full Text] [Related]
6. Chemotherapy of metastatic colorectal cancer: fluorouracil plus folinic acid and irinotecan or oxaliplatin.
Prescrire Int; 2005 Dec; 14(80):230-3. PubMed ID: 16400749
[TBL] [Abstract][Full Text] [Related]
7. New oxaliplatin-based combinations in the treatment of colorectal cancer.
Cassidy J; Hochster H
Colorectal Dis; 2003 Nov; 5 Suppl 3():1-9. PubMed ID: 23573555
[TBL] [Abstract][Full Text] [Related]
8. Irinotecan, oxaliplatin and raltitrexed for the treatment of advanced colorectal cancer.
Cao S; Bhattacharya A; Durrani FA; Fakih M
Expert Opin Pharmacother; 2006 Apr; 7(6):687-703. PubMed ID: 16556086
[TBL] [Abstract][Full Text] [Related]
9. New developments in systemic chemotherapy in advanced colorectal cancer.
Cats A
Scand J Gastroenterol Suppl; 2003; (239):78-86. PubMed ID: 14743888
[TBL] [Abstract][Full Text] [Related]
10. Raltitrexed/5-fluorouracil-based combination chemotherapy regimens in anticancer therapy.
Caponigro F; Avallone A; Budillon A; Comella P; Comella G
Anticancer Drugs; 2001 Jul; 12(6):489-97. PubMed ID: 11459994
[TBL] [Abstract][Full Text] [Related]
11. Second-Line Treatment of Advanced Colorectal Cancer with a Biweekly Oxaliplatin plus Irinotecan Combination Regimen.
Schüll B; Kornek GV; Schmid K; Raderer M; Ulrich-Pur H; Fiebiger W; Schneeweiss B; Lenauer A; Depisch D; Scheithauer W
Onkologie; 2002 Aug; 25(4):358-62. PubMed ID: 12232488
[TBL] [Abstract][Full Text] [Related]
12. Raltitrexed (Tomudex) in combination with platinum-based agents and/or anthracyclines: preliminary results of phase I clinical trials.
Armand JP; Seymour L; Evans TR
Eur J Cancer; 1999 Mar; 35 Suppl 1():S14-8. PubMed ID: 10645209
[TBL] [Abstract][Full Text] [Related]
13. Clinical advances with topoisomerase I inhibitors in gastrointestinal malignancies.
Armand JP; Cunningham D; van Cutsem E; Misset JL; Kohne CH
Anticancer Drugs; 1999 Nov; 10 Suppl 1():S5-12. PubMed ID: 10630362
[TBL] [Abstract][Full Text] [Related]
14. Safe administration of irinotecan, oxaliplatin and raltitrexed in a DPD-deficient patient with metastatic colon cancer.
Volk J; Reinke F; van Kuilenburg AB; van Gennip AH; Schlichting C; Ganser A; Schöffski P
Ann Oncol; 2001 Apr; 12(4):569-71. PubMed ID: 11398894
[TBL] [Abstract][Full Text] [Related]
15. Oxaliplatin: a new therapeutic option in colorectal cancer.
Cvitkovic E; Bekradda M
Semin Oncol; 1999 Dec; 26(6):647-62. PubMed ID: 10606258
[TBL] [Abstract][Full Text] [Related]
16. Raltitrexed and mitomycin-C as third-line chemotherapy for colorectal cancer after combination regimens including 5-fluorouracil, irinotecan and oxaliplatin: a phase II study.
Rosati G; Rossi A; Germano D; Reggiardo G; Manzione L
Anticancer Res; 2003; 23(3C):2981-5. PubMed ID: 12926149
[TBL] [Abstract][Full Text] [Related]
17. [New therapeutic options in chemotherapy of advanced colorectal cancer].
Reimer P; Rückle-Lanz H
Med Klin (Munich); 2001 Oct; 96(10):593-8. PubMed ID: 11715331
[TBL] [Abstract][Full Text] [Related]
18. Randomized multicenter phase II trial of oxaliplatin plus irinotecan versus raltitrexed as first-line treatment in advanced colorectal cancer.
Scheithauer W; Kornek GV; Raderer M; Ulrich-Pur H; Fiebiger W; Gedlicka C; Schüll B; Brugger S; Schneeweiss B; Lang F; Lenauer A; Depisch D
J Clin Oncol; 2002 Jan; 20(1):165-72. PubMed ID: 11773166
[TBL] [Abstract][Full Text] [Related]
19. Phase II randomised trial of raltitrexed-oxaliplatin vs raltitrexed-irinotecan as first-line treatment in advanced colorectal cancer.
Feliu J; Castañón C; Salud A; Mel JR; Escudero P; Pelegrín A; López-Gómez L; Ruiz M; González E; Juárez F; Lizón J; Castro J; González-Barón M;
Br J Cancer; 2005 Nov; 93(11):1230-5. PubMed ID: 16265344
[TBL] [Abstract][Full Text] [Related]
20. Developments in combination chemotherapy for colorectal cancer.
Goetz MP; Grothey A
Expert Rev Anticancer Ther; 2004 Aug; 4(4):627-37. PubMed ID: 15270666
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
